Express Scripts/Medco Merger Faces Longer Odds After FTC's Second Request
Executive Summary
Following the Federal Trade Commission’s second request for additional information about Express Scripts Inc.'s proposed acquisition of Medco Health Solutions Inc., it is now statistically likely that the deal will be blocked or subject to a divestiture.
You may also be interested in...
Express Scripts-Medco Merger Closes With No Divestitures Needed
The FTC voted in a split 3-1 vote to close its investigation and allow Express Scripts’ $29.1 billion acquisition of rival PBM Medco to proceed.
Payer Support For Express Scripts’ “Transition” From Walgreens Shows Depth Of Interest In Drug Benefit Savings, PBM Says
During Express Scripts’ earnings call Feb. 23, CEO George Paz said the pharmacy benefit manager’s clients are willing to tolerate the potential inconvenience of a smaller pharmacy network, without Walgreens, because it can save them real money.
Express Scripts-Medco Specialty Pharmacy Combination Is Key To Merger, CEO Affirms
Express Scripts would be unwilling to proceed with merger with Medco if FTC says the firm’s specialty drug division must be spun off, CEO George Paz tells Senate subcommittee.